ITİlGiz Tüzken

İlGiz Tüzken

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


İlGiz Tüzken has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pancreatic duct stenting during pancreaticoduodenectomy: outcomes from a standardized duct-to-mucosa cohort with propensity score weighting

    by Mustafa Anıl Turhan, Alp Togan Kıraç, Kaan Sünter, İlGiz Tüzken, Elvan Onur Kırımker, Mehmet Kaan Karayalçın, Acar Tüzüner

    Background Postoperative pancreatic fistula (POPF) remains one of the most important complications after pancreaticoduodenectomy (PD), and the optimal transanastomotic pancreatic duct drainage strategy remains debated. Aims To evaluate the association between pancreatic duct stenting strategy and clinically relevant POPF (CR-POPF) after PD. Methods We retrospectively analyzed consecutive open PDs (2010–2020). Only patients undergoing standardized duct-to-mucosa pancreaticojejunostomy with a transanastomotic stent (external or internal) were included. The cohort comprised 302 patients (external n = 238; internal n = 64). The primary outcome was CR-POPF (ISGPS grade B–C). Propensity score–based inverse probability of treatment weighting (IPTW) was applied. Results CR-POPF occurred in 9.9% of patients and was lower with external versus internal stenting (8.0% vs. 17.2%, p = 0.029). Biliary leak was also less frequent with external stenting (4.6% vs. 14.1%, p = 0.019). In IPTW-weighted analysis, external stenting was independently associated with lower odds of CR-POPF (OR 0.31, 95% CI 0.14–0.70; p = 0.005). E-value analysis suggested moderate robustness to unmeasured confounding (E-value 5.9). Thirty-day mortality was numerically lower with external stenting (2.5% vs. 7.8%, p = 0.059). Conclusions External pancreatic duct stenting was associated with lower CR-POPF rates after standardized PD. Prospective randomized studies are needed to confirm these findings and guide stenting strategy selection.


  • Open Access

    Persistent oxidized regenerated cellulose mimicking locoregional recurrence after thyroidectomy: diagnostic challenges and associated risk factors

    by Mustafa Anıl Turhan, İlGiz Tüzken, Mustafa Şahin, Atilla Halil Elhan, Koray Ceyhan, Volkan Genç

    Oxidized regenerated cellulose (ORC) is widely used as a local hemostatic agent during thyroid surgery. Although manufacturers report complete absorption within 7-14 days, persistent ORC is frequently observed in postoperative follow-up, often mimicking residual or recurrent thyroid tissue. This misinterpretation can result in unnecessary investigations or biopsies. The present study aimed (1) to define the ultrasonographic features of persistent ORC to prevent misleading radiological interpretations and (2) to identify the risk factors associated with delayed ORC resorption. A retrospective review was conducted on 145 consecutive patients who underwent thyroid surgery between May 2022 and April 2024. Ultrasonographic follow-up findings were analyzed to identify persistent ORC. Potential clinical and hematological predictors of delayed absorption were evaluated. Statistical analyses included chi-square tests, t-tests, and Cox regression models to determine independent risk factors influencing ORC persistence. Persistence of ORC was significantly associated with a history of reoperation (p = 0.002), presence of coronary artery disease (p = 0.006), low neutrophil count (< 3.785 × 10⁹/L; p = 0.003), and the use of the Pahacel® brand of ORC. In contrast, ORC from the Surgicel® brand showed significantly faster absorption. These findings suggest that both patient-related and product-related factors contribute to the delayed resorption of ORC. Persistent ORC may mimic recurrent thyroid tissue on postoperative imaging. Awareness of its ultrasonographic appearance and understanding of related risk factors are essential to avoid unnecessary diagnostic procedures. Surgeons, endocrinologists, and radiologists should exercise caution during postoperative assessment, especially in patients with risk factors for delayed absorption. This study is a retrospective analysis and was not prospectively registered.

  • Open Access

    Autotransplanted parathyroid adenoma as a rare cause of primary hyperparathyroidism: focused literature review

    by İlGiz Tüzken, Mustafa Anıl Turhan, Ayşegül Gürsoy Çoruh, İrEm Şeker, Mustafa Şahin, Volkan Genç

    Background/aim: Primary hyperparathyroidism (PHPT) is usually caused by a parathyroid adenoma. Parathyroid autotransplantation is commonly performed during thyroidectomy when gland perfusion is impaired. However, the development of adenomas in autotransplanted tissue is extremely rare. We present a case of PHPT caused by an adenoma arising from autotransplanted parathyroid tissue, which occurred 30 years after total thyroidectomy. Methods: A 60-year-old woman with a history of total thyroidectomy and parathyroid autotransplantation to the sternocleidomastoid muscle presented with hypercalcemia and elevated parathyroid hormone levels. Ultrasonography suggested a small lesion, but sestamibi scintigraphy was negative. Definitive localization was achieved using 4D-CT and targeted ultrasonography. Results: Minimally invasive parathyroidectomy was performed, and intraoperative PTH level decreased from 318 pg/mL to 70 pg/mL. Histopathology confirmed a parathyroid adenoma originating from autotransplanted tissue. Postoperatively, calcium and PTH levels normalized. Conclusion: Adenoma formation in autotransplanted parathyroid tissue is very rare but may occur even decades after surgery. Clinicians should systematically evaluate previous autotransplantation sites when they are investigating unexplained or recurrent PHPT, even decades after thyroid or parathyroid surgery.